Alpha Tau Medical Ltd
Research Alpha Tau Medical Ltd (DRTS) on Bullrun: market cap USD 1.01B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDRTS
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.01B
- Financial periodFY2025
- Net income-USD 42.63M
- Free cash flow-USD 32.76M
Valuation Snapshot
latest market cap is USD 1.01B.
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Frequently asked questions
What is Alpha Tau Medical Ltd's market cap?
Alpha Tau Medical Ltd's market capitalization is USD 1.01B.
What does Alpha Tau Medical Ltd do?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.